The Lundquist Institute for BioMedical Innovation at Harbor-UCLA Medical Center is a clinical research site located in Torrance, California, United States 90502.
Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.
The Lundquist Institute for BioMedical Innovation at Harbor-UCLA Medical Center has participated in 3 clinical trials.
Therapeutic areas: Mucopolysaccharidosis (MPS), Hunter Syndrome, HIV-1 Infection.
Sponsors: Takeda, Gilead Sciences.
Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
The Lundquist Institute for BioMedical Innovation at Harbor-UCLA Medical Center has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
The Lundquist Institute for BioMedical Innovation at Harbor-UCLA Medical Center has 3 clinical trials on record. Their work covers Mucopolysaccharidosis (MPS), Hunter Syndrome, HIV-1 Infection.
The Lundquist Institute for BioMedical Innovation at Harbor-UCLA Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.